{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"TP53, a tumor suppressor in the DNA damage pathway, is the most frequently mutated gene in cancer.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":"LEVEL_Px1",
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"04/20/2017",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "7651437"
      ]
    },
    "description":"The TP53 R283Q mutation occurs in the protein's DNA binding domain. In biochemical assays, this TP53 mutant had a decreased ability to bind DNA compared to wildtype TP53 (PMID: 7651437).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "25412851",
        "25860933"
      ],
      "tumorType":{
        "children":{},
        "code":"AMLMRC",
        "color":"LightSalmon",
        "id":17,
        "level":4,
        "mainType":{
          "id":null,
          "name":"Leukemia",
          "tumorForm":"LIQUID"
        },
        "name":"AML with Myelodysplasia-Related Changes",
        "parent":"AML",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "22186996",
        "18596741"
      ],
      "tumorType":{
        "children":{},
        "code":"AML",
        "color":"LightSalmon",
        "id":527,
        "level":3,
        "mainType":{
          "id":null,
          "name":"Leukemia",
          "tumorForm":"LIQUID"
        },
        "name":"Acute Myeloid Leukemia",
        "parent":"MNM",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "25412846",
        "25952993"
      ],
      "tumorType":{
        "children":{},
        "code":"TMN",
        "color":"LightSalmon",
        "id":418,
        "level":4,
        "mainType":{
          "id":null,
          "name":"Leukemia",
          "tumorForm":"LIQUID"
        },
        "name":"Therapy-Related Myeloid Neoplasms",
        "parent":"AML",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "23243274",
        "24004666",
        "20697090",
        "19188171",
        "24652989"
      ],
      "tumorType":{
        "children":{},
        "code":"CLLSLL",
        "color":"LimeGreen",
        "id":533,
        "level":5,
        "mainType":{
          "id":null,
          "name":"Mature B-Cell Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
        "parent":"MBN",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "21714648",
        "25092778",
        "24220272"
      ],
      "tumorType":{
        "children":{},
        "code":"MDS",
        "color":"LightSalmon",
        "id":355,
        "level":3,
        "mainType":{
          "id":null,
          "name":"Myelodysplastic Syndromes",
          "tumorForm":"LIQUID"
        },
        "name":"Myelodysplastic Syndromes",
        "parent":"MNM",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "24478400",
        "29296692",
        "22887079"
      ],
      "tumorType":{
        "children":{},
        "code":"ET",
        "color":"LightSalmon",
        "id":695,
        "level":4,
        "mainType":{
          "id":null,
          "name":"Myeloproliferative Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Essential Thrombocythemia",
        "parent":"MPN",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "25516983",
        "22052707",
        "22887079"
      ],
      "tumorType":{
        "children":{},
        "code":"MPN",
        "color":"LightSalmon",
        "id":185,
        "level":3,
        "mainType":{
          "id":null,
          "name":"Myeloproliferative Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Myeloproliferative Neoplasms",
        "parent":"MNM",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px1",
      "pmids":[
        "25516983",
        "22052707",
        "22887079"
      ],
      "tumorType":{
        "children":{},
        "code":"PMF",
        "color":"LightSalmon",
        "id":632,
        "level":4,
        "mainType":{
          "id":null,
          "name":"Myeloproliferative Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Primary Myelofibrosis",
        "parent":"MPN",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px3",
      "pmids":[
        "8639789",
        "7579380",
        "28819011",
        "24684350",
        "26022239"
      ],
      "tumorType":{
        "children":{},
        "code":"MCL",
        "color":"LimeGreen",
        "id":586,
        "level":5,
        "mainType":{
          "id":null,
          "name":"Mature B-Cell Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Mantle Cell Lymphoma",
        "parent":"MBN",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    }
  ],
  "prognosticSummary":"",
  "query":{
    "alteration":"R283H",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":7157,
    "hgvs":"17:g.7673772C>T",
    "hugoSymbol":"TP53",
    "id":null,
    "proteinEnd":283,
    "proteinStart":283,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The TP53 R283H mutation has not been functionally or clinically validated. However, TP53 R283Q is likely oncogenic, and therefore TP53 R283H is considered likely oncogenic.",
  "vus":false
}